We partner with lead investors in early-stage strategic clients.

Innovatemap Ventures

Fulcrum Equity Partners is a growth equity firm investing in high-growth SaaS, tech-enabled services, healthcare services and healthcare IT companies.  Founded in 2006 and based in Atlanta, GA, Fulcrum has raised over $280 million across three funds and has invested in more than 30 companies.    Fulcrum will consider non-control and control investments, and provides capital to meet a variety of needs including internal growth initiatives, acquisitions, divestitures, shareholder liquidity, management buyouts and recapitalizations.  The partners have over 125 years of relevant experience, including operations, venture capital, mezzanine financing, accounting, law, investment banking and strategy consulting.  For more information, please visit www.fulcrumep.com.

Fulcrum Equity Partners

Due to the lack of venture capital outside the major tech hubs, we created Mutual Capital Partners in 2004 to lead or co-lead investments in promising companies looking for venture capital. Our focus is on medical device and healthcare IT companies. Management is a key focus for us and we work with the 100+ investors in our funds to assist us in due diligence, make customer introductions for our portfolio companies, and provide ongoing advice and counsel to our portfolio executives.

Mutual Capital Partners

Olio

Olio is an information technology company that offers a mobile-based software application platform that transforms post-acute engagement during this crisis and beyond. Olio gives health systems real-time visibility into patient location and status. The company was founded in 2017 by Ben Forrest and headquartered in Carmel, Indiana.

<div><p>Indiana-based Olio is a developer of practice management software for healthcare providers. The company&rsquo;s platform allows providers to track patient journeys, improve real-time communication and workflows and collaboration between healthcare workers, manage finance and billings, and carry out data analysis of key operational metrics. The company also preemptively monitors patients and raises alerts preemptively.&nbsp;&nbsp;</p></div>

More important now than ever, telehealth will long outlast the pandemic that drove its growth.

Telehealth

<div><p>Olio is an information technology company that offers a mobile-based software application platform that transforms post-acute engagement during this crisis and beyond. Olio gives health systems real-time visibility into patient location and status. The company was founded in 2017 by Ben Forrest and headquartered in Carmel, Indiana.</p></div>

Simplifying healthcare administration with intuitive tech tools

Hospital Management

<div>
  <p>
    Indiana-based Olio is a developer of practice management software for healthcare providers. The company&rsquo;s platform allows providers to track patient journeys, improve real-time communication and workflows and collaboration between healthcare workers, manage finance and billings, and carry out data analysis of key operational metrics. The company also preemptively monitors patients and raises alerts preemptively.&nbsp;&nbsp;
  </p>
  <p>
    The company targets value-based payers and post-acute care facilities.
  </p>
  <p>
    <b>Funding and financials</b>
  </p>
  <p>
    In August 2022, Olio raised USD 13 million in a Series A funding round led by Fulcrum Equity Partners, along with participation from another venture firm. The company set aside these funds for accelerating its growth through product development and to hire additional staff across several departments.&nbsp;
  </p>
  <p>
  </p>
</div>


<div>
  <p>
    Nice Healthcare is a US based telehealth company with a focus on primary care services to business-to-business (B2B) clients. Once the employer signs its employees with Nice (at a cost of USD 30 to USD 36 per employee per month), employees do not have to incur out of pocket expenses for Nice services and can schedule virtual or home visits within the time frames specified by the company. It connects patients with practitioners through a mobile app over video calls or text messages. Members can also request home visits which will be completed within a few hours, as claimed by the company. As of March 2022, Nice was operating in twelve states, and had over 400 small and medium enterprises (SMEs).
  </p>
  <p>
    In March 2022, the company raised USD 30 million in Series A financing led by DNA Capital which has been earmarked to expand its platform&rsquo;s reach among small and medium businesses. Additionally, the company is hiring three members for its management team to support the continuing growth of the organization.
  </p>
  <p>
  </p>
</div>


Nice Healthcare

<p><span>Amicomed is a cloud-based Software-as-a-Service (SaaS) platform which provides blood pressure monitoring services. It collects blood pressure data of patients from at-home devices, applies algorithms, and assesses the fluctuations in the blood pressure. Physicians can be connected and provided with blood pressure data of their patients in order to facilitate their workload, enabling more personalized management of patients regarding medication and lifestyle indications.</span></p><p><span>Amicomed can also recommend actionable and personalized lifestyle interventions such as daily diet and exercises via virtual coaching.</span></p>

Amicomed

<p><span>Winston is a men’s health telemedicine platform that treats common issues impacting men such as sexual problems, hair loss, acne, and cold sores. Winston allows patients to consult doctors, place orders for prescription drugs, and offers free delivery to the homes of patients.</span></p><p><span>The Toronto-based company aims to avoid men deferring doctor visits or withholding sensitive information. The consultation fee is covered by the provincial health plan, but the prescriptions are billed to the customer.</span></p>

Winston

<p><span>Eko Health is a digital health company that has developed an AI-powered platform for detecting heart and lung diseases during routine physical examinations. The company's flagship product, SENSORA, comprises digital stethoscopes integrated with advanced algorithms that can identify structural heart murmurs, low ejection fraction (indicative of heart failure), and atrial fibrillation.</span></p>
<p><span>In June 2024, Eko Health raised USD 41 million in a Series D funding round to scale its disease detection platform globally. The company's murmur detection algorithm, cleared by the FDA, was clinically validated in a study at Massachusetts General Hospital, demonstrating a two-fold increase in identifying structural heart murmurs compared to standard practice. Furthermore, Eko's low ejection fraction algorithm, developed in collaboration with Mayo Clinic, significantly improved the detection of heart failure with reduced ejection fraction in a study conducted at Imperial College London.</span></p>
<p><span>Eko Health's technology aims to reduce diagnostic bottlenecks and enhance patient outcomes by facilitating early detection of cardiac and pulmonary diseases. With over 500,000 healthcare professionals utilizing its FDA-cleared platform worldwide as of June 2024, the company has established a substantial presence in the market.</span></p>
<p><span>In June 2023, Eko Health launched its next-generation digital stethoscope, CORE 500, featuring advanced capabilities such as a full-color display, 3-lead electrocardiogram (ECG), and TrueSound technology for optimal sound filtering. The CORE 500 received FDA 510(k) clearance and seamlessly integrates with the SENSORA platform.</span></p>
<p><b><strong>Key customers and partnerships</strong></b></p>
<p><span>In November 2023, Eko Health announced a large-scale deployment of its AI-enabled technology through the TRICORDER program, an implementation initiative led by Imperial College London and funded by the National Institute for Health and Care Research (NIHR). The program aims to deploy Eko's technology to 100 General Practitioner (GP) practices across the UK, assisting clinicians in evaluating heart failure, valvular heart disease, and atrial fibrillation.</span></p>
<p><span>Additionally, Eko Health has partnered with leading academic institutions such as Massachusetts General Hospital and Mayo Clinic to validate the clinical utility and positive impact of its technology on patient care.</span></p>
<p><br></p>

Eko Health

<div>
  <p>
    Dialogue partners with employers and health insurers to offer telehealth services to their employees and members. The users have 24/7 access to doctors, nurses, and other healthcare professionals via audio, video, and chat options for wide arrays of physical and mental health needs, artificial intelligence-enabled (AI-enabled) triage, referrals, and prescription renewals. 
  </p>
  <p>
    The company launched its trademarked Integrated Health Platform in January 2021 to consolidate its virtual care,  wellness programs, mental healthcare services, and Employee Assistance Program (EAP) onto a single platform. The company claims to be the only integrated health and wellness B2B platform in Canada. 
  </p>
  <p>
    <b>Key Customers and partnerships</b>
  </p>
  <p>
    Dialogue had direct relationships with over 2,000 customers across Canada and Germany as of December 2020 and served around 50,000 organizations through these partnerships. In addition, the number of members with access to the virtual platform topped 1 million in January 2021. 
  </p>
  <p>
    <b>Fundings and financials</b>
  </p>
  <p>
    As of March 2021, Dialogue was planning to raise CAD 100 million (USD 80 million) from an initial public offering that will be listed on the Toronto Stock Exchange under the ticker symbol &ldquo;CARE.&rdquo; 
  </p>
  <p>
    In Q2 2023, net losses reduced significantly YoY to CAD 5.8 million (USD 4.3 million) from CAD 8.4 million (USD 6.3 million) in Q2 2022. Top-line revenue met internal expectations, growing 17.2% YoY to CAD 25.5 million (USD 19.0 million), driven by &nbsp;an increase in new members (by 18.6% YoY), 
    an expansion of the attach rate as existing customers added more services, and full-quarter contributions from Tictrac.
     
    Dialogue Health has not provided any forward-looking guidance as the company has entered into an agreement to be 
    <a href="https://investors.dialogue.co/English/news/news-details/2023/Dialogue-to-be-Acquired-by-Sun-Life/default.aspx">
      <u>acquired by financial services company Sun Life Financial</u>
    </a>
     for a consideration of CAD 365 million (USD 270 million) or CAD 5.15 (USD 3.82) per share. The transaction is expected to close in Q4 2023. Post acquisition, Dialogue will delist from the Toronto Stock Exchange but will continue to operate as a standalone entity under the &ldquo;Sun Life Canada&rdquo; brand from its head office in Qu&eacute;bec. 
  </p>
  <p>
  </p>
</div>


Dialogue

Real-time collection of patients’ health-related data using any remote patient monitoring device combined with general telemedicine services to reduce readmission rates. 


A platform that facilitates the transmission of patient data to different locations for further evaluation and interpretation by medical specialists. 


A digital platform that offers specialty care services to address the specific needs of a patient or demographic, including consultations where patients are generally reluctant to meet practitioners face-to-face.

Primary care through virtual consultations for general health-related concerns using a digital platform or mobile app. 

Companies developing B2B software solutions for patient engagement, care navigation, practice management, and electronic health records integration to facilitate telehealth services for healthcare providers. 

IoT is used by most telehealth providers to operate virtual services

All telehealth players are involved in digital health via virtual offerings

Industry players offer varying degrees of personalization for each target audience

Some players offer technology and platforms to healthcare providers, converting physical-only services into virtual services

Specific telehealth offerings focus on diversity and inclusion, providing care to LGBTQ+ or BIPOC populations

Generative AI is used to streamline administrative tasks such as clinical note-taking

<div>
  <p>
    Olio is an information technology company that offers a mobile-based software application platform that transforms post-acute engagement during this crisis and beyond. Olio gives health systems real-time visibility into patient location and status. The company was founded in 2017 by Ben Forrest and headquartered in Carmel, Indiana.
  </p>
</div>


<div>
  <p>
    ModMed is transforming healthcare by placing doctors and patients at the center of care through an intelligent, specialty-specific cloud platform. Their specialty-specific, data-driven, and cloud-based electronic health records (EHR) and practice management (PM) systems, plus revenue cycle management (RCM) services, were built by a team including specialty physicians and practice management professionals.
  </p>
</div>


Modernizing Medicine

<div>
  <p>
    Kyruus delivers proven provider search and scheduling solutions that help hospitals and health systems match patients with the providers best suited to care for them. The ProviderMatch suite of solutions&mdash;for consumers, access centers, and referral networks&mdash;enables a consistent patient experience across multiple points of access, while aligning provider supply with patient demand. The company&rsquo;s proprietary provider data management platform forms the foundation of its solutions, powering them with accurate data by coupling data processing with administrative applications. Kyruus was founded in 2010 and is headquartered in Boston, Massachusetts.
  </p>
</div>


Kyruus

<div>
  <p>
    AKASA is an AI-powered automation company for revenue cycle management in healthcare. The company provides hospitals with Unified Automation services, which is a flexible AI-based solution that automates complex operational tasks such as those related to revenue cycle management. Its approach imbues the entire automation process with human judgment and subject matter expertise. Unified Automation operates within a hospital's existing electronic health record (EHR) and revenue cycle infrastructure to reduce errors and improve efficiencies.
  </p>
</div>


AKASA

<div>
  <p>
    XSOLIS is a healthcare technology firm focused on improving healthcare operations through cognitive computing. By aligning cognitive computing behind clinical expertise, we're creating a new framework for decision-making.
  </p>
</div>


XSOLIS

<div>
  <p>
    Suki is an AI-powered, voice-enabled digital assistant for doctors. It was designed to help healthcare organizations with their administrative tasks. Suki helps physicians in dictating notes, retrieving info, and working with EHR. The company was founded in 2017 and is headquartered in Redwood City, California.
  </p>
</div>


Suki

Platforms used by hospitals to manage the various aspects of patient care to improve overall efficiency, such as automating routine tasks, improving communication and coordination among healthcare providers, and enhancing patient outcomes within the hospital setting

Platforms that enable patients to actively participate in their healthcare journey by educating and engaging them, along with improving communication with healthcare providers

Platforms that help healthcare organizations analyze patient data and other performance metrics to improve decision-making and optimize resource allocation

Platforms that are designed to help hospitals and health systems manage their financial operations from patient billing and insurance claims to revenue tracking and analysis

AI-powered software solutions that are designed to help healthcare organizations streamline and automate the process of documenting patient encounters

IoT medical solutions turn traditional hospitals into smart hospitals, allowing them to streamline workflows

AI/ML algorithms optimize workflows, enable predictive modeling, and analyze patient data in healthcare

Offers software platforms that streamline and improve hospital operations

Olio

About EDGE

Contact Us

Resources

Area of Focus

Technology Research Made Effortless